Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Supplementary Table from Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication

Hiroto Inaba, Jolieke G. van Oosterwijk,John C. Panetta,Lie Li,Daelynn R. Buelow,James S. Blachly, Sheila Shurtleff,Ching-Hon Pui,Raul C. Ribeiro, Jeffrey E. Rubnitz,Stanley Pounds,Sharyn D. Baker

openalex（2023）

Cited 0|Views31
No score
Abstract
Supplementary Table from Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication
More
Translated text
Key words
flt3 tyrosine kinase inhibitor,acute myeloid leukemia,sorafenib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined